
It is probably too early to categorically declare that Covid-19 has been beaten. But on the day that we emerge from Lockdown 2, news that Pfizer’s vaccine has been approved for use in the UK will surely have lifted the nation’s spirits – even if the market’s reaction was more muted than it had been previously on news of trial results.
OPINION
On your bike
Turning a trend into consistent profit isn’t always that easy
John Hughman